Moscow has implemented three standards for the use of AI in medicine
11 January 2024
Three initial standards for the secure implementation of artificial intelligence (AI) in the field of medicine were enforced in Moscow on January 1, 2024. They will be in effect for three years, said the capital’s mayor Sergei Sobyanin.
Positive data from schizophrenia clinical trials revealed
10 January 2024
Newron Pharmaceuticals and Lyndra Therapeutics’ have announced positive data from key clinical trials in schizophrenia and schizoaffective disorder.
Collaboration to develop novel AI-designed oncology therapy
10 January 2024
Stemline Therapeutics is set to pay Insilico Medicine an initial $12 million for its novel AI-designed KAT6 inhibitor as a potential breast cancer treatment.
Russian authorities are launching an experimental API traceability system
09 January 2024
On Friday, December 29, Russia will begin an exciting experiment to implement a traceability system for the origin of drugs and pharmaceutical substances. It will last until December 31, 2024, following from the Decree of the Government of the Russian Federation No. 2261 of December 22, 2023, which appeared on the official Internet portal of legal information.
The Russian government plans to develop a system for expediting the registration of medicines
09 January 2024
Prime Minister Mikhail Mishustin has issued a directive to draft a law aimed at regulating the development and registration of medical technologies in Russia. This is one of the stages for the implementation of the “megaproject” to improve the pharmaceutical industry, announced earlier.
Federal Anti-Monopoly Service reported 252 essential drug cost reduction
29 December 2023
Since the beginning of 2023, it has been possible to reduce prices for 252 drugs within the framework of 40 international nonproprietary name’s (INNs) , which are included in the list of vital and essential drugs. This was reported in the press service of the Federal Antimonopoly Service.
In 2023, Russia registered 30 vaccines and 81 pharmaceuticals for animals
29 December 2023
As part of import substitution, Russian manufacturers registered 30 veterinary vaccines and 81 pharmaceutical products for animals in 2023, the press service of the Federal Service for Veterinary and Phytosanitary Supervision (Rosselkhoznadzor) reported to Veterinary and Life Journal. In addition, in 2022, 22 Russian veterinary vaccines and 74 pharmaceuticals were registered for the purpose of import substitution.
Additional 1.6 billion rubles for goods and equipment in federal budget
28 December 2023
Prime Minister of the Russian Federation Mikhail Mishustin signed order No. 3881-r dated December 23, 2023, according to which an additional 1.6 billion rubles will be allocated from the reserve fund to provide disabled people with technical means of rehabilitation.
In November, Russia produced drugs worth 61 billion rubles
28 December 2023
According to the Federal State Statistics Service – Rosstat, the production of medicines in Russia in November 2023 increased by 33% compared to the same period last year – to 61 billion rubles.
2024 forecast: Digital therapeutics makers will have to get creative to conquer reimbursement issues
27 December 2023
The science behind digital therapeutics may sound dubious on paper—a smartphone app that can help someone quit smoking, reverse Type 2 diabetes or treat depression.
14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
Big Pharma’s ROI for drug R&D saw 'welcome' rebound in 2023: report
25 April 2024
Orphan drug market to reach $270B by 2028 : Evaluate
25 April 2024
Russian drug for the treatment of viral hepatitis will be exempt from duty in Mongolia
24 April 2024
PM Mishustin: “We need to increase the production of vital and essential drugs in Russia”
24 April 2024